Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
Portfolio Pulse from Avi Kapoor
The article highlights three oversold health care stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are Aslan Pharmaceuticals Ltd (NASDAQ:ASLN), CERo Therapeutics Holdings Inc (NASDAQ:CERO), and Organovo Holdings Inc (NASDAQ:ONVO).
July 18, 2024 | 11:55 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ASLAN Pharmaceuticals announced the voluntary liquidation of its Singapore-incorporated subsidiary, leading to a 69% drop in stock price over the past five days. The RSI value is 25.34, indicating the stock is oversold.
The voluntary liquidation of its sole operating subsidiary is a significant negative event, leading to a sharp decline in stock price. The low RSI value indicates the stock is oversold, but the liquidation news is likely to have a negative short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
CERo Therapeutics executed pre-IND manufacturing activities for its lead therapeutic, CER-1236. Despite a 33% drop in stock price over the past month, the RSI value of 20.79 indicates the stock is oversold.
The completion of pre-IND manufacturing activities is a positive development. Despite the recent drop in stock price, the low RSI value suggests the stock is oversold and may present a buying opportunity.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Organovo presented its outlook and plans at the Jones Trading Healthcare Conference. The stock dipped 18% over the past five days, with an RSI value of 20.53 indicating it is oversold.
The presentation at a healthcare conference is a neutral to positive event. The recent dip in stock price and low RSI value suggest the stock is oversold, potentially offering a buying opportunity.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70